The focus of this month’s blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis ... News Medical: Combination drug treatment could be effective against malignant peripheral nerve sheath tumors A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) - soft tissue tumors that are stubbornly resistant to chemotherapy and radiation - ... Combination drug treatment could be effective against malignant peripheral nerve sheath tumors Science Daily: Experimental drug combination shows promise against hard-to-treat peripheral nerve sheath tumors Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies.
Combining a pair of ... News Medical: The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance Correlation of Snail expression and survival in patients with early-stage triple-negative breast cancer (TNBC). Background: Malignant peripheral nerve sheath tumors (MPNST) constitute a group of ... ascopubs.org: Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives Kaleido Scope: The Difference in Treatment Options for Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath Tumors The Difference in Treatment Options for Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath Tumors A new mini review was published in Oncotarget's Volume 15 on , entitled, "Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath ...
